SARTORIUS AG-VORZUG (SRT3.DE) Stock Fundamental Analysis
Europe - FRA:SRT3 - DE0007165631
222 EUR
-1.7 (-0.76%)
We assign a fundamental rating of 3 out of 10 to SRT3. SRT3 was compared to 18 industry peers in the Life Sciences Tools & Services industry. Both the profitability and financial health of SRT3 have multiple concerns. SRT3 is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SRT3 was profitable.
In the past year SRT3 had a positive cash flow from operations.
In the past 5 years SRT3 has always been profitable.
Each year in the past 5 years SRT3 had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.39%, SRT3 is doing worse than 83.33% of the companies in the same industry.
The Return On Equity of SRT3 (5.01%) is worse than 77.78% of its industry peers.
SRT3's Return On Invested Capital of 4.71% is on the low side compared to the rest of the industry. SRT3 is outperformed by 77.78% of its industry peers.
SRT3 had an Average Return On Invested Capital over the past 3 years of 8.34%. This is in line with the industry average of 7.57%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROIC | 4.71% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
1.3 Margins
Looking at the Profit Margin, with a value of 3.80%, SRT3 is doing worse than 83.33% of the companies in the same industry.
In the last couple of years the Profit Margin of SRT3 has declined.
SRT3's Operating Margin of 14.06% is on the low side compared to the rest of the industry. SRT3 is outperformed by 66.67% of its industry peers.
In the last couple of years the Operating Margin of SRT3 has declined.
The Gross Margin of SRT3 (46.48%) is better than 72.22% of its industry peers.
In the last couple of years the Gross Margin of SRT3 has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% |
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
2. Health
2.1 Basic Checks
SRT3 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
SRT3 has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SRT3 has more shares outstanding
Compared to 1 year ago, SRT3 has an improved debt to assets ratio.
2.2 Solvency
SRT3 has an Altman-Z score of 2.31. This is not the best score and indicates that SRT3 is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.31, SRT3 is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
SRT3 has a debt to FCF ratio of 8.92. This is a slightly negative value and a sign of low solvency as SRT3 would need 8.92 years to pay back of all of its debts.
SRT3 has a worse Debt to FCF ratio (8.92) than 66.67% of its industry peers.
A Debt/Equity ratio of 1.28 is on the high side and indicates that SRT3 has dependencies on debt financing.
SRT3 has a worse Debt to Equity ratio (1.28) than 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Altman-Z | 2.31 |
ROIC/WACC0.63
WACC7.53%
2.3 Liquidity
SRT3 has a Current Ratio of 0.95. This is a bad value and indicates that SRT3 is not financially healthy enough and could expect problems in meeting its short term obligations.
SRT3 has a Current ratio of 0.95. This is amonst the worse of the industry: SRT3 underperforms 88.89% of its industry peers.
A Quick Ratio of 0.49 indicates that SRT3 may have some problems paying its short term obligations.
SRT3 has a Quick ratio of 0.49. This is amonst the worse of the industry: SRT3 underperforms 94.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 |
3. Growth
3.1 Past
SRT3 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 59.34%, which is quite impressive.
SRT3 shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.87% yearly.
SRT3 shows a small growth in Revenue. In the last year, the Revenue has grown by 5.82%.
SRT3 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.10% yearly.
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
3.2 Future
The Earnings Per Share is expected to grow by 19.16% on average over the next years. This is quite good.
Based on estimates for the next years, SRT3 will show a quite strong growth in Revenue. The Revenue will grow by 8.92% on average per year.
EPS Next Y23.27%
EPS Next 2Y20.61%
EPS Next 3Y22.38%
EPS Next 5Y19.16%
Revenue Next Year5.14%
Revenue Next 2Y7.17%
Revenue Next 3Y8.54%
Revenue Next 5Y8.92%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
SRT3 is valuated quite expensively with a Price/Earnings ratio of 48.68.
Based on the Price/Earnings ratio, SRT3 is valued more expensive than 88.89% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.67, SRT3 is valued quite expensively.
Based on the Price/Forward Earnings ratio of 37.24, the valuation of SRT3 can be described as expensive.
Based on the Price/Forward Earnings ratio, SRT3 is valued more expensive than 83.33% of the companies in the same industry.
SRT3's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 31.86.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.68 | ||
| Fwd PE | 37.24 |
4.2 Price Multiples
61.11% of the companies in the same industry are cheaper than SRT3, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SRT3 is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.73 | ||
| EV/EBITDA | 22.26 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SRT3's earnings are expected to grow with 22.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.09
PEG (5Y)N/A
EPS Next 2Y20.61%
EPS Next 3Y22.38%
5. Dividend
5.1 Amount
SRT3 has a yearly dividend return of 0.39%, which is pretty low.
SRT3's Dividend Yield is comparable with the industry average which is at 0.72.
Compared to an average S&P500 Dividend Yield of 2.40, SRT3's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.39% |
5.2 History
The dividend of SRT3 has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
SRT3 pays out 37.92% of its income as dividend. This is a sustainable payout ratio.
SRT3's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP37.92%
EPS Next 2Y20.61%
EPS Next 3Y22.38%
FRA:SRT3 (11/7/2025, 5:36:15 PM)
222
-1.7 (-0.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners4.37%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.62B
Revenue(TTM)3.52B
Net Income(TTM)133.70M
Analysts80
Price Target330.38 (48.82%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.39% |
Yearly Dividend0.74
Dividend Growth(5Y)3.71%
DP37.92%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.85%
Min EPS beat(2)-10.52%
Max EPS beat(2)4.83%
EPS beat(4)1
Avg EPS beat(4)-3.47%
Min EPS beat(4)-10.52%
Max EPS beat(4)4.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)0.83%
Revenue beat(4)3
Avg Revenue beat(4)1.91%
Min Revenue beat(4)-0.73%
Max Revenue beat(4)4.87%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.98%
PT rev (3m)-7.25%
EPS NQ rev (1m)3.45%
EPS NQ rev (3m)3.45%
EPS NY rev (1m)0%
EPS NY rev (3m)0.3%
Revenue NQ rev (1m)2.71%
Revenue NQ rev (3m)2.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.68 | ||
| Fwd PE | 37.24 | ||
| P/S | 4.73 | ||
| P/FCF | 34.73 | ||
| P/OCF | 19.01 | ||
| P/B | 6.23 | ||
| P/tB | N/A | ||
| EV/EBITDA | 22.26 |
EPS(TTM)4.56
EY2.05%
EPS(NY)5.96
Fwd EY2.68%
FCF(TTM)6.39
FCFY2.88%
OCF(TTM)11.68
OCFY5.26%
SpS46.97
BVpS35.63
TBVpS-35.24
PEG (NY)2.09
PEG (5Y)N/A
Graham Number60.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROCE | 6.33% | ||
| ROIC | 4.71% | ||
| ROICexc | 4.98% | ||
| ROICexgc | 17.77% | ||
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% | ||
| FCFM | 13.61% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
ROICexc(3y)8.77%
ROICexc(5y)11.17%
ROICexgc(3y)24.37%
ROICexgc(5y)31.52%
ROCE(3y)11.22%
ROCE(5y)14.06%
ROICexgc growth 3Y-35.26%
ROICexgc growth 5Y-11.95%
ROICexc growth 3Y-38.49%
ROICexc growth 5Y-19.53%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Debt/EBITDA | 3.69 | ||
| Cap/Depr | 92.32% | ||
| Cap/Sales | 11.25% | ||
| Interest Coverage | 2.65 | ||
| Cash Conversion | 94.72% | ||
| Profit Quality | 357.97% | ||
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 | ||
| Altman-Z | 2.31 |
F-Score7
WACC7.53%
ROIC/WACC0.63
Cap/Depr(3y)148.03%
Cap/Depr(5y)150.65%
Cap/Sales(3y)13.71%
Cap/Sales(5y)12.64%
Profit Quality(3y)282.77%
Profit Quality(5y)224.27%
High Growth Momentum
Growth
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
EPS Next Y23.27%
EPS Next 2Y20.61%
EPS Next 3Y22.38%
EPS Next 5Y19.16%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
Revenue Next Year5.14%
Revenue Next 2Y7.17%
Revenue Next 3Y8.54%
Revenue Next 5Y8.92%
EBIT growth 1Y18.65%
EBIT growth 3Y-21.66%
EBIT growth 5Y4.31%
EBIT Next Year99.69%
EBIT Next 3Y38.21%
EBIT Next 5Y26.49%
FCF growth 1Y123.33%
FCF growth 3Y7.25%
FCF growth 5Y29.73%
OCF growth 1Y6.61%
OCF growth 3Y4.07%
OCF growth 5Y20.79%
SARTORIUS AG-VORZUG / SRT3.DE FAQ
What is the ChartMill fundamental rating of SARTORIUS AG-VORZUG (SRT3.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to SRT3.DE.
What is the valuation status for SRT3 stock?
ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS AG-VORZUG (SRT3.DE). This can be considered as Overvalued.
Can you provide the profitability details for SARTORIUS AG-VORZUG?
SARTORIUS AG-VORZUG (SRT3.DE) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for SRT3 stock?
The Price/Earnings (PE) ratio for SARTORIUS AG-VORZUG (SRT3.DE) is 48.68 and the Price/Book (PB) ratio is 6.23.
What is the expected EPS growth for SARTORIUS AG-VORZUG (SRT3.DE) stock?
The Earnings per Share (EPS) of SARTORIUS AG-VORZUG (SRT3.DE) is expected to grow by 23.27% in the next year.